MadSci Network: Genetics |
Question: How would an alteration of a cell's DNA affect the cell? From: James L. Gouldsmith Email: AdrienVeidt@yahoo.com Grade: nonaligned City: Savannah, State/Prov.: Georgia Country: USA Area: Genetics Message ID Number: 929171605.Ge In detail, say a new color-determining gene were to replace the previous gene in a person's right eye by how I understand gene therapy to operate. It is my understanding that every cell in the human body is replaced every seven years. After seven years, would the right eye now have a different color? If so, what (other than the actual knowlege of how to effect the mechanics) would prevent a person from becoming an entirely different person through an enormous, entire-DNA code replacement? Will it be possible to improve the current height of an adult human through such a process? Grow out of diabetes? Change gender? Change species? Dear James: Greetings! Wow! Your question is insightful and you have touched on several complicated issues regarding gene therapy. I will try to address most of them here, but only in broad terms. (I'll warn you now that I have written a lot here!!) If you are interested in more "nitty-gritty" details, I shall refer you to some sources where you can find more in-depth information. Generally speaking, gene therapy is a process whereby exogenous DNA is delivered to human cells as a treatment for a particular disease. In some cases, the new DNA contains a "good" copy of a certain gene because the patient has a defective copy contained in his or her cells. This is the theory behind the use of gene therapy to treat metabolic diseases, many of which are due to a genetic mutation in a single enzyme required for normal metabolism. In other cases, DNA is being delivered not because there are specific mutations in the patient's own gene, but rather because the patient's copy isn't actively making protein in a large enough quantity, at the appropriate time and location. This is the rationale for treating patients with blocked coronary arteries in their heart, often causing severe chest pain ('angina'), with a gene for the growth factor VEGF (Vascular Endothelial Growth Factor). Ideally, this growth factor will stimulate the growth of new blood vessels in the heart and relieve patients' chest pain. In this situation, there isn't anything specifically wrong with an individual's VEGF gene-there just simply isn't enough of the protein in the right place to get the job done. There are several factors which influence the efficacy of gene therapy, only a few of which we are beginning to understand. Two of the major issues are (1) effective gene transfer and (2) stable gene expression. The main hurdle regarding the first point is how the gene of interest will be introduced into a cell, so it can travel to the nucleus and ultimately incorporate into the patient's DNA. "Naked DNA", meaning just the gene alone, does not find its way into cells very efficiently. For the most part, genes need to be targeted to cells using "carrier DNA" known as a vector. Many methods of gene delivery are currently focused on using viruses as vectors for gene therapy. Normally, during the process of viral infection, a virus must get its DNA into host cells and "hijack" the cells' metabolic machinery in order to propagate itself. Thus, since viruses already have these capabilities, they are a logical choice for use in gene therapy. By inserting the gene of interest into the genome of a particular virus, one can create a package for gene delivery. While simple in theory, this approach is not without its drawbacks. The second point, achieving stable gene expression, simply means that the exogenous gene needs to insert itself into the patient's own DNA in order to be continually converted into protein. This is not a trivial concern, because only a small percentage of the cells that receive gene therapy will incorporate the piece of DNA into their genome. Another issue to consider is whether the gene will be delivered to a patient's cells while they are still in the body ('in vivo'), or alternatively, whether a small number of cells will be removed from the body, propagated in a petri dish ('in vitro'), and then treated with the gene of interest. Then, these cells can be reintroduced into the patient. To address some of the specifics you mention in your question, I would first like to dispel a common myth, the origin of which I am uncertain. Every cell in the human body is not replaced every seven years. There are many cell types in the human body, each with different capabilities for renewal. For example, the muscle cells in your heart cannot replace themselves-this is one reason why a heart attack can inflict such severe damage to the heart. If the heart muscle cells are deprived of oxygen for too long (due to blocked coronary arteries, for instance), they die and cannot regenerate, leaving the heart weakened and structurally compromised. The neurons in your brain and spinal cord are another example of a cell population that can rarely, if ever, regenerate. In contrast, the cells that line the gastrointestinal tract proliferate rapidly-the lining of the gut is turned over about once every three days. With regard to the pigmented cells in the iris which give eyes their color, it is likely that they are also a non-renewing cell population. What would happen if you replaced a color-determining gene in the eye with another color-determining gene? As far as I understand, we do not yet have the technical capabilities for "gene replacement" in humans. There is a subtle, but important distinction between gene therapy and gene replacement. With gene therapy, a gene is delivered which will ultimately integrate randomly into the genome of a particular cell. Exactly where it inserts itself isn't a major concern, at least in principle. Currently, we do not have the ability to target where a gene integrates-for instance, whether it jumps into the site occupied by a color-determining gene or some other gene. Essentially, what prevents a person from becoming an entirely different person through an "enormous, entire DNA code replacement" is the limitations of gene therapy as a technique. The odds of getting stable gene expression in a cell population are rather low. However, if one can achieve a decent level of gene expression, it is then important to consider the types of cells that are modified. If, for example, you hit a cell that is rapidly replaced, such as the cells that line the gut, this can be a problem. The cells may be genetically modified, but since they are sloughed from the gut lining every three days, they will be lost. One way to remedy this is to try and select a special subset of these cells, often referred to as stem cells, which have special properties. Stem cells are like cellular Xerox machines-they are constantly dividing and renewing the cells that die. So, if one could effectively target a particular stem cell with gene X, then this cell will continue to make copies of itself and replace the dying cells with new cells, all of which will contain gene X. However, this is much easier said than done because all tissues in the human body do not have stem cells, or at least, we haven't identified them yet! I don't think gene therapy will be a feasible technique for altering the current height or gender of an individual. These are qualities that are most certainly under the control of many genes and are acquired during a long process of growth and development. Along those lines, I do not foresee gene therapy as a means for changing species in the near or distant future. It will be a significant triumph if we can successfully implement techniques for correcting single gene disorders. These other things are complicated entities under genetic as well as environmental control. However, gene therapy may hold promise as a treatment for diabetes. While this may not be a single gene disorder, it is essentially due to the lack of control over blood glucose levels. In some forms of diabetes, this is due to the lack of insulin-producing cells in the pancreas. Therefore, it may be possible to deliver the insulin gene to some other cells in the body to restore the proper regulation of blood glucose. Whew! I hope this information helps (and there certainly is a lot of it!). Please feel free to email me with further questions! I have listed a couple references below. Nikki nmdavis@fas.harvard.edu Introduction to Gene Therapy, a website for a course at Vanderbilt University. An article on gene therapy in Scientific American in October 1996-perhaps a bit out-of-date, but still worth reading. The American Society for Gene Therapy Towards gene therapy of diabetes mellitus. Molecular Medicine Today. 1999 5(4):165-171. This article describes some of the approaches to gene therapy for diabetes. If you are interested and can't find it at your library, contact me and I will send you a copy.
Try the links in the MadSci Library for more information on Genetics.